The Transsexual Adult

Swaytha Yalamanchi, Betiel Fesseha, Adrian S Dobs

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Overall, data suggest an increase in transgendered-related diagnoses, possibly reflecting accelerated openness and awareness in both the lay and medical communities about health concerns specific to transsexual individuals. It is hypothesized that a combination of prenatal sex hormonal milieu, genetics, and differences in sexually dimorphic brain structures may be important in the pathophysiology of transsexualism. The diagnosis of transsexualism is generally made by a mental health professional and it is key to identify potential psychiatric comorbidities prior to consideration of hormonal or surgical therapy. Both the Endocrine Society guidelines and WPATH Standards of Care provide excellent clinical guidance on the management of transsexual adults. Gender-affirming hormone therapy for transsexual women typically includes an antiandrogen agent and estrogen and for transsexual men includes testosterone. If the decision to go forward with gender-affirming surgery is made, it is recommended that individuals live as the desired gender for at least 1 year prior. Prior to going forward with hormone or surgical therapy, it is important to address fertility preservation. Lifelong surveillance is recommended to address the unique primary care concerns of this population. There is a clear need for well-conducted research in characterizing health disparities, comorbid disease, and the effects of gender-affirming hormonal and surgical interventions on morbidity, mortality, and quality of life.

Original languageEnglish (US)
Title of host publicationPrinciples of Gender-Specific Medicine
Subtitle of host publicationGender in the Genomic Era: Third Edition
PublisherElsevier
Pages91-105
Number of pages15
ISBN (Print)9780128035061
DOIs
StatePublished - May 15 2017

Fingerprint

Transsexualism
Hormones
Transgender Persons
Fertility Preservation
Androgen Antagonists
Health
Standard of Care
Psychiatry
Testosterone
Comorbidity
Primary Health Care
Mental Health
Estrogens
Therapeutics
Quality of Life
Guidelines
Morbidity
Mortality
Brain
Research

Keywords

  • Gender affirming hormone therapy
  • Gender affirming surgery
  • Transgender
  • Transsexual

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yalamanchi, S., Fesseha, B., & Dobs, A. S. (2017). The Transsexual Adult. In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition (pp. 91-105). Elsevier. https://doi.org/10.1016/B978-0-12-803506-1.00015-2

The Transsexual Adult. / Yalamanchi, Swaytha; Fesseha, Betiel; Dobs, Adrian S.

Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition. Elsevier, 2017. p. 91-105.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yalamanchi, S, Fesseha, B & Dobs, AS 2017, The Transsexual Adult. in Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition. Elsevier, pp. 91-105. https://doi.org/10.1016/B978-0-12-803506-1.00015-2
Yalamanchi S, Fesseha B, Dobs AS. The Transsexual Adult. In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition. Elsevier. 2017. p. 91-105 https://doi.org/10.1016/B978-0-12-803506-1.00015-2
Yalamanchi, Swaytha ; Fesseha, Betiel ; Dobs, Adrian S. / The Transsexual Adult. Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition. Elsevier, 2017. pp. 91-105
@inbook{cf37ebaf26da4e93b5ecb6bd7cf95ff0,
title = "The Transsexual Adult",
abstract = "Overall, data suggest an increase in transgendered-related diagnoses, possibly reflecting accelerated openness and awareness in both the lay and medical communities about health concerns specific to transsexual individuals. It is hypothesized that a combination of prenatal sex hormonal milieu, genetics, and differences in sexually dimorphic brain structures may be important in the pathophysiology of transsexualism. The diagnosis of transsexualism is generally made by a mental health professional and it is key to identify potential psychiatric comorbidities prior to consideration of hormonal or surgical therapy. Both the Endocrine Society guidelines and WPATH Standards of Care provide excellent clinical guidance on the management of transsexual adults. Gender-affirming hormone therapy for transsexual women typically includes an antiandrogen agent and estrogen and for transsexual men includes testosterone. If the decision to go forward with gender-affirming surgery is made, it is recommended that individuals live as the desired gender for at least 1 year prior. Prior to going forward with hormone or surgical therapy, it is important to address fertility preservation. Lifelong surveillance is recommended to address the unique primary care concerns of this population. There is a clear need for well-conducted research in characterizing health disparities, comorbid disease, and the effects of gender-affirming hormonal and surgical interventions on morbidity, mortality, and quality of life.",
keywords = "Gender affirming hormone therapy, Gender affirming surgery, Transgender, Transsexual",
author = "Swaytha Yalamanchi and Betiel Fesseha and Dobs, {Adrian S}",
year = "2017",
month = "5",
day = "15",
doi = "10.1016/B978-0-12-803506-1.00015-2",
language = "English (US)",
isbn = "9780128035061",
pages = "91--105",
booktitle = "Principles of Gender-Specific Medicine",
publisher = "Elsevier",

}

TY - CHAP

T1 - The Transsexual Adult

AU - Yalamanchi, Swaytha

AU - Fesseha, Betiel

AU - Dobs, Adrian S

PY - 2017/5/15

Y1 - 2017/5/15

N2 - Overall, data suggest an increase in transgendered-related diagnoses, possibly reflecting accelerated openness and awareness in both the lay and medical communities about health concerns specific to transsexual individuals. It is hypothesized that a combination of prenatal sex hormonal milieu, genetics, and differences in sexually dimorphic brain structures may be important in the pathophysiology of transsexualism. The diagnosis of transsexualism is generally made by a mental health professional and it is key to identify potential psychiatric comorbidities prior to consideration of hormonal or surgical therapy. Both the Endocrine Society guidelines and WPATH Standards of Care provide excellent clinical guidance on the management of transsexual adults. Gender-affirming hormone therapy for transsexual women typically includes an antiandrogen agent and estrogen and for transsexual men includes testosterone. If the decision to go forward with gender-affirming surgery is made, it is recommended that individuals live as the desired gender for at least 1 year prior. Prior to going forward with hormone or surgical therapy, it is important to address fertility preservation. Lifelong surveillance is recommended to address the unique primary care concerns of this population. There is a clear need for well-conducted research in characterizing health disparities, comorbid disease, and the effects of gender-affirming hormonal and surgical interventions on morbidity, mortality, and quality of life.

AB - Overall, data suggest an increase in transgendered-related diagnoses, possibly reflecting accelerated openness and awareness in both the lay and medical communities about health concerns specific to transsexual individuals. It is hypothesized that a combination of prenatal sex hormonal milieu, genetics, and differences in sexually dimorphic brain structures may be important in the pathophysiology of transsexualism. The diagnosis of transsexualism is generally made by a mental health professional and it is key to identify potential psychiatric comorbidities prior to consideration of hormonal or surgical therapy. Both the Endocrine Society guidelines and WPATH Standards of Care provide excellent clinical guidance on the management of transsexual adults. Gender-affirming hormone therapy for transsexual women typically includes an antiandrogen agent and estrogen and for transsexual men includes testosterone. If the decision to go forward with gender-affirming surgery is made, it is recommended that individuals live as the desired gender for at least 1 year prior. Prior to going forward with hormone or surgical therapy, it is important to address fertility preservation. Lifelong surveillance is recommended to address the unique primary care concerns of this population. There is a clear need for well-conducted research in characterizing health disparities, comorbid disease, and the effects of gender-affirming hormonal and surgical interventions on morbidity, mortality, and quality of life.

KW - Gender affirming hormone therapy

KW - Gender affirming surgery

KW - Transgender

KW - Transsexual

UR - http://www.scopus.com/inward/record.url?scp=85032633815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032633815&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803506-1.00015-2

DO - 10.1016/B978-0-12-803506-1.00015-2

M3 - Chapter

AN - SCOPUS:85032633815

SN - 9780128035061

SP - 91

EP - 105

BT - Principles of Gender-Specific Medicine

PB - Elsevier

ER -